Resources:
Find resources by:
Sort by:
Resources from the last:
Box size:
Filer text box:
Topic familiarity:
Grid Layout:
Collections that use this topic:
Collection topics:
Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Diabetes Glucagon

Islets Insulin BetaCells Pancreas Glucose Hyperglycemia Hypoglycemia Insulinoma Glucagon IGF Type 1 Type 2
Semaglutide approved as obesity treatment in England
2022-02-1717Feb2022
Autoinjector is better for dispensing glucagon
2019-07-1111Jul2019
Autoinjector is better for dispensing glucagon
2019-07-1111Jul2019
Early Career Grants awarded
2019-01-0808Jan2019
Early Career Grants awarded
2019-01-0808Jan2019
New potential target to help treat diabetes
2018-12-1717Dec2018
Lowering sodium uptake in alpha cells may help treat type-2 diabetes
2018-11-1616Nov2018
A type-2 diabetes treatment may increase the need for lower limb amputation
2018-11-1616Nov2018
Clinical Biochemistry PhD at the University of Cambridge
2018-10-1212Oct2018
Nasal glucagon safe for children
2018-04-1717Apr2018
Crystal structure of glucagon receptor key for type 2 diabetes drug development
2018-01-0505Jan2018
Type 2 diabetes therapy may prevent memory loss
2018-01-0202Jan2018
The gut plays a key role in the development of type 2 diabetes
2017-08-0707Aug2017
New technique colours biomolecules in tissue
2017-04-2020Apr2017
Post-bariatric hypoglycemia prevented through novel glucagon pump
2017-04-0606Apr2017
Glucagon receptor antagonist ups blood pressure in type 2 diabetes
2017-02-2424Feb2017
Zebrafish as models of mammalian glucagon action
2016-02-2626Feb2016
Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish
2015-11-2525Nov2015
GLP-1 may play a major role in reproduction
2015-08-1919Aug2015
Stability of GLP-1 and glucagon in human plasma
2015-03-2626Mar2015
Next generation of prescription diet pills could increase risk of colon cancer
2015-03-0404Mar2015
Glucagonoma-induced acute heart failure
2014-12-1919Dec2014
Impact of DPP4 inhibition on incretin effect
2014-09-2929Sep2014
GLP1–ANP axis in humans?
2014-03-1212Mar2014
PCOS, weight reduction and liraglutide
2014-03-1212Mar2014
Multihormone reverses metabolic damage of high calorie diet (Alpha Galileo, 15 January 2014)
2014-01-1616Jan2014
Appetite hormone misfires in obese people (EurekAlert, 20 August 2013)
2013-08-2121Aug2013
Scripps Research Institute scientists find 3D structure of key drug target for diabetes (AlphaGalileo, 17 July 2013)
2013-07-1818Jul2013
Effects of GLP1R agonists on primary thyroid C-cells
2013-06-1212Jun2013
Proglucagon sorting in endocrine cells
2013-05-0808May2013
Fellowship: Development and validation of models of glucagon and amylin action in healthy and type 1 diabetic subjects, Padova, Italy
2013-01-1717Jan2013
Most-used diabetes drug works in different way than previously thought (EurekAlert, 6 January 2013)
2013-01-0707Jan2013
New findings on glucagon synthesis (EurekAlert, 3 December 2012)
2012-12-0707Dec2012
PhD Fellowship in diabetes, Université Catholique de Louvain, Belgium
2012-07-1616Jul2012
Plenary lecture 7 'Diabetes as a gut disease' 10:45, Main Hall
2012-04-3030Apr2012
Post-doc fellowship, Université Catholique de Louvain, Belgium
2012-02-1313Feb2012
Regulation of glucose homeostasis
2012-01-0303Jan2012
Research Associate (two positions), University of Cambridge
2011-12-1313Dec2011
Postdoctoral fellow, Brussels, Belgium
2011-11-1414Nov2011
Simple gut hormone combo makes our brains think we're full (EurekAlert, 25 October 2011)
2011-10-2626Oct2011
Simple gut hormone combo makes our brains think we're full (EurekAlert, 25 October 2011)
2011-10-2626Oct2011
Post-doctoral position, Université Catholique de Louvain, Belgium
2011-10-0404Oct2011
A study on glucagonoma
2011-05-0909May2011
New drug for diabetics could end ordeal of daily insulin jabs (Daily Mail, 25 January 2010)
2010-01-2626Jan2010
The Impact of Subcutaneous Infusions of three Anorexigenic Gut Hormones Glucagon-like Peptide-1, Oxy...
Date not available
Glucagon-like peptide-1 secretion within the developing human fetus and its role in beta cell develo...
Date not available
Glucagon Increases Energy Expenditure Independently of Brown Adipose Tissue Activation in Humans
Date not available
Does glucagon need the brain for its effects on blood glucose?
Date not available
Does glucagon need the brain for its effects on blood glucose?
Date not available
Does glucagon need the brain for its effects on blood glucose?
Date not available
Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study
Date not available
GLP-1 and glucagon co-secretion due to a pancreatic neuroendocrine tumour causing diabetes and subse...
Date not available
The use of glucagon for management of severe-persistent hypoglycaemia in patients with congenital hy...
Date not available
Debate - PRO: Use of Dual Hormone (glucagon) v. single hormone (insulin) in the treatment of diabetes with close-loop system
Date not available
Debate - CON: Use of Dual Hormone (glucagon) v. single hormone (insulin) in the treatment of diabetes with close-loop system
Date not available
Pharmacokinetics of Intravenous Glucagon in Children with Hyperinsulinaemic Hypoglycaemia
Date not available
Expression and localisation of insulin, glucagon, amylin, pancreatic polypeptide and PDX-1 in pancre...
Date not available
Dasiglucagon safety in paediatric participants with CHI
Date not available
Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: Preliminary experience from a tertiary paediatric endocrine centre
Date not available
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
Date not available
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
Date not available
Project to Develop BSPED UK Standardised Guidelines for Sex Hormone Priming and Glucagon Stimulation...
Date not available
Project to Develop BSPED UK Standardised Guidelines for Sex Hormone Priming and Glucagon Stimulation...
Date not available
Comparison of patient experiences of the glucagon and insulin pituitary provocation tests: time for ...
Date not available
A gut feeling about glucagon
Date not available
Glucose-dependent insulinotropic peptide (GIP) stimulates Glucagon-like peptide (GLP)-1 from human a...
Date not available
Novel glucagon receptor antagonist peptides improve glycaemic control and partially protect against ...
Date not available
Development of severe gastroparesis and gastric food bezoar following administration of glucagon-like peptide 1-receptor agonist (GLP1-RA) therapy.
Date not available
Lipid handling by the glucagon family of G protein-coupled receptors
Date not available
Glucagonomas: diagnostic features and outcomes of first line treatment in a series of 18 patients
Date not available
Glucagon-like peptide 1 receptor is required for optimal bone strength and quality
Date not available
Resource not read: Query You and Your Hormones
Prolonged acidosis in SGLT2i-induced euglycaemic diabetic ketoacidosis
2019-12-1818Dec2019
How do I ... develop new diabetes drugs by studying natural peptide hormones in patients?
2017-03-0808Mar2017
SEX-BASED IMPACT OF PANCREATIC ISLET STRESSORS IN GluCreERT2/Rosa26-eYFP MICE
2023-12-1515Dec2023
GENETIC SYNDROMES LINKED TO INSULINOMA AND GLUCAGONOMA
2024-06-1818Jun2024
GLP-1 receptor activation and cancer cell chemosensitivity
2020-03-1212Mar2020
PRECONCEPTION TREATMENT WITH METFORMIN OR EXENATIDE IN PCOS
2022-09-1616Sep2022
Mechanisms of β cell dedifferentiation in diabetes
2021-09-2222Sep2021
A Big Bang in Birmingham! Time for endocrine inspiration
2018-06-0606Jun2018
A NEW ERA IN OBESITY MANAGEMENT
2022-06-2323Jun2022
OBESITY AND TYPE 2 DIABETES: TIME TO PUT AWAY THE KNIVES?
2022-12-1414Dec2022
FAQs (fat accumulation and quality) in non-alcoholic steatohepatitis
2017-12-1919Dec2017
Towards self-management in type 1 diabetes
2018-09-1919Sep2018
POLYCYSTIC OVARY SYNDROME: THE HUNT FOR NEW THERAPIES
2022-12-1414Dec2022
STRESS, TRAUMA AND LATE EFFECTS OF BRAIN TUMOURS
2024-09-1717Sep2024
24 hours in the life of a hormone: what time is the right time for a pituitary function test?
2023-12-2222Dec2023
GDF15: SOMATIC DISTRESS, APPETITE AND AVERSION
2021-12-1515Dec2021
SPECIALIST PHARMACISTS IN ENDOCRINOLOGY AN EVOLVING ROLE
2022-06-2323Jun2022
Endogenous insulin: its role in the initiation, progression and management of diabetes
2018-09-1919Sep2018
119.pdf
2018-04-1111Apr2018
075.pdf
2018-04-1111Apr2018
107.pdf
2018-04-1111Apr2018
Endocrinologist 123 Web
2023-11-0101Nov2023
The Endocrinologist Autumn 14 -website.pdf
2018-04-1111Apr2018
073.pdf
2018-04-1111Apr2018
Endocrinologist 144 Web
2022-06-2121Jun2022
109.pdf
2018-04-1111Apr2018
086.pdf
2018-04-1111Apr2018
087.pdf
2018-04-1111Apr2018
Endocrinologist 134 Web Updated
2023-11-0101Nov2023
Endocrinologist 146 Web
2022-12-0707Dec2022
Endocrinologist 153 Web Version
2024-10-1515Oct2024
088.pdf
2018-04-1111Apr2018
Endocrinologist 129 Web
2023-11-0101Nov2023
083.pdf
2018-04-1111Apr2018
110.pdf
2018-04-1111Apr2018
The Endocrinologist 115 Web FINAL.pdf
2018-04-1111Apr2018
Endocrinologist 145 Web
2022-09-0505Sep2022
Endocrinologist 150 Web
2023-12-0707Dec2023
Endocrinologist 152 Final For Web
2024-06-1717Jun2024
108.pdf
2018-04-1111Apr2018
100.pdf
2018-04-1111Apr2018
The Endocrinologist 117 Web.pdf
2018-04-1111Apr2018
Endocrinologist 126
2023-11-0101Nov2023
Endocrinologist 128 Web Updated
2023-11-0101Nov2023
Endocrinologist 142 Web (1)
2023-10-0505Oct2023
Endocrinologist 142 Web
2021-12-0606Dec2021
ScreenSummerEndoComplete.pdf
2018-04-1111Apr2018
Endocrinologist 135 Web
2023-11-0101Nov2023
Endocrinologist 141 Web
2023-11-0101Nov2023
Orexin-A inhibits glucagon secretion and proglucagon gene expression
Date not available
A gut feeling about glucagon
2018-08-0505Aug2018
Pharmacokinetics of Intravenous Glucagon in Children with Hyperinsulinaemic Hypoglycaemia
Date not available
Glucagon activity in human adipose precursors
2019-01-0505Jan2019
Glucagon stimulates cholecystokinin secretion in humans
2010-01-0404Jan2010
Use of Dual Hormone (Glucagone) vs Single Hormone (Insulin) in the Treatment of Diabetes with Closed-loop System
Date not available
Glucagon Therapy In Preterm Infants With Hyperinsulinemic Hypoglycaemia
Date not available
Glucagon Secretion in Response to Hypoglycemia in Patients with Congenital Hyperinsulinism
Date not available
Glucagon levels in women with Alzheimer’s disease
Date not available
Inhaled glucagon, a new well-accepted therapeutic tool in pediatrics
Date not available
The use of glucagon in the treatment of hypoglycaemia due to congenital hyperinsulinism
2015-04-1111Apr2015
Does glucagon need the brain for its effects on blood glucose?
2014-01-0303Jan2014
Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study
2013-01-0303Jan2013
EFFECTS OF GLUCOSE, INSULIN, GLUCAGON AND NICOTINE ON CULTURED FIBROBLASTS
2002-01-1111Jan2002
Somatostatin receptor subtype 2 inhibits glucagon secretion and regulates glucose homeostasis
Date not available
Interactions between glucagon and GLP-1 in neuronal pathways affecting food intake
2011-01-0404Jan2011
Similar developmental patterns of ghrelin and glucagon immunoreactivity in the human pancreas
2010-01-0404Jan2010
Plasma Glucagon and Somatostatin Levels in Children with Congenital Hyperinsulinism During Hypoglycaemia
Date not available
The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21
Date not available
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
2015-12-1010Dec2015
Adrenocortical, somatotropic and antidiuretic response to nasal glucagon in healthy subjects
2023-02-0505Feb2023
Glucagon suppression of total but not of acylated ghrelin is preserved in obesity: the impact on appetite control
2008-01-0505Jan2008
Cortisol but not GH responses are dependent on symptoms during the glucagon stimulation test
Date not available
The Use of Glucagon for Management of Severe-Persistent Hypoglycaemia in Patients with Congenital Hyperinsulinism
Date not available
Identifying the amino acids which mediates the effect of protein on glucagon release
Date not available
Challenges in diagnosing and treating a glucagon secreting tumor – case report
2019-01-0505Jan2019
Effect of pre and postnatal diet on pancreatic beta-cell insulin and glucagon content
2009-01-0303Jan2009
Continuous intravenous glucagon in children with congenital hyperinsulinism: A retrospective single center evaluation of effects and adverse effects
Date not available
Glucagon tolerance tests in a tertiary paediatric centre: an evidence-base for protocol refinement
Date not available
Normal Ranges of Basal and Glucagon-Stimulated Free Cortisol in Children
Date not available
Comparison of patient experiences of the glucagon and insulin pituitary provocation tests: time for a reappraisal
2012-01-1111Jan2012
Determinants of the Peak GH Response of the Glucagon Stimulation Test in Slowly Growing Children
Date not available
A comparison of the neuronal populations within the nucleus tractus solitarius activated by peripheral administration of glucagon, GLP-1 and oxyntomodulin
2012-01-0303Jan2012
Critical evaluation of the diagnostic utility of the simplified intramuscular glucagon stimulation test (IMGST)
2008-01-0404Jan2008
Lack of cortisol response using the glucagon stimulation test in diabetic autonomic neuropathy
2002-01-0303Jan2002
Glucagon-induced suppression of ghrelin secretion is exerted at hypothalamus-pituitary level and is not mediated by an increase in catecholamine secretion
2006-04-1212Apr2006
Use of Dual Hormone (Glucagon) v. Single Hormone (Insulin) in the Treatment of Diabetes with Close-loop System
Date not available
Pancreatic glucagon-like-peptide-1 receptor expression in congenital hyperinsulinism
2021-06-0909Jun2021
The expression and prognostic value of somatostatin and glucagon-like peptide 1 receptors in insulinoma
2024-06-0505Jun2024
Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial
2012-01-0505Jan2012
Pancreatic Glucagon Secretion is Severely Impaired and Somatostatin Secretion Unchanged in Patients with Hyperinsulinaemic Hypoglycaemia
Date not available
Glucagon vs Clonidine Stimulation for Testing Growth Hormone Secretion in Children and Adolescents: Which is Better?
Date not available
Glucagon Testing of Childhood-Onset Growth Hormone Deficiency during Transition
2021-06-0909Jun2021
Cortisol levels in glucagon stimulation tests in children evaluating for short stature: clinical and laboratorial correlations
Date not available
Glucagon-like peptide-1 stimulates insulin secretion and then somatostatin secretion in rat islets
2015-01-0505Jan2015
Comparison of Glucagon vs Clonidine stimulation test to diagnose growth hormone deficiency
2013-01-1111Jan2013
Glucagon-like peptide-1 responses following multiple meals in lean and obese subjects
2008-01-0404Jan2008
Effects of Glucagon-Like-Peptide-1 analogue treatment in genetic obesity
Date not available
Increased Glucagon-Like Peptide-1 Response to Oral Glucose in Prepubertal Obese Children
Date not available
Glucagon-like peptide 1 receptor is required for optimal bone strength and quality
2013-01-0505Jan2013
Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial
2010-01-0404Jan2010
The accuracy of diagnosing adrenal insufficiency in children undergoing glucagon stimulation test (GST)
2012-01-1111Jan2012
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
Date not available
Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind randomized placebo-controlled study
2022-07-0505Jul2022
Evaluation of copeptin levels during glucagon stimulation test in children with suspected growth hormone deficiency
2022-07-0505Jul2022
Activation of GPR120 by lipid agonists modulates glucagon secretion in pancreatic islets and improves glucose tolerance in mice
2015-01-0505Jan2015
The Relation Between Serum Glucose and Growth Hormone Concentrations During Standard Glucagon Test for GH Release in Short Stature Children
Date not available
GLP-1RAs and glucagon can reshape adipose differentiation in vitro by activating the “browning process”
2022-07-0505Jul2022
Comparative Study of Glucose Response to Intramuscular Glucagon in Pediatric Growth Hormone Deficiency and Idiopathic Short Stature: What is the risk of hypoglycemia?
Date not available
GLP-1 and glucagon depict complementary actions on visceral adipose tissue that could mediate metabolic shifts towards catabolism
2022-07-0505Jul2022
Cell-cell contact enhances insulin secretion from pancreatic beta-cells but not glucagon secretion from alpha-cells
2004-01-1111Jan2004
Does the glucagon challenge test add to the utility of a 72 h fast for spontaneous hypoglycemia?
2011-01-0404Jan2011
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
2018-08-0505Aug2018
Glucagon Response to Hypoglycemia During Extended Oral Glucose Tolerance Test in Children with Cystic Fibrosis and Comparing with Healthy Peers
Date not available
Comparison of 1 μg ACTH, 250 μg ACTH and glucagon tests for assessment of the hypothalamo-pituitary–adrenal axis in healthy subjects
2010-01-0404Jan2010
Novel glucagon receptor antagonist peptides improve glycaemic control and partially protect against streptozotocin induced diabetes in mice
2015-01-0505Jan2015
Comparative analysis of the methods for differential diagnosis of non-diabetic hypoglycemia (NDH): Beta-hydroxybutyrate and glucagon test
Date not available
Expression and Localisation of Insulin, Glucagon, Amylin, Pancreatic Polypeptide and PDX-1 in Pancreatic Tissue of Children with Congenital Hyperinsulinism
Date not available
10.25 A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with T1DM in the home or school setting
2018-11-0909Nov2018
A not so sweet glucagonoma
2018-09-0404Sep2018
Project to develop BSPED UK standardised guidelines for sex hormone priming and glucagon stimulation testing (GST) in children and adolescents
2019-11-1111Nov2019
Elimination of fall in glucose during glucagon stimulation test does not completely abolish an increase in growth hormone and cortisol concentrations
2024-06-0505Jun2024
Evaluation of minutes related to the maximum levels and random basal levels of growth hormone during stimulation test with glucagon
Date not available
Pharmacogenomics and efficacy outcome of therapy with glucagon-like peptide-1 receptor agonists in type 2 diabetes
2022-07-0505Jul2022
Bright and specific far-red labels for visualizing endogenous glucagon-like peptide-1 receptors
2018-02-1111Feb2018
Copeptin concentrations increase during glucagon stimulation test: possible role of copeptin in assessment of anterior pituitary function
Date not available
Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases
2011-01-0404Jan2011
Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases
2011-01-0404Jan2011
Comparison of the low dose synacthen and glucagon stimulation tests in the assessment of adrenal function in children with short stature
2010-01-1111Jan2010
10.17. Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and preclinical models of insulin-deficient diabetes
2022-12-0909Dec2022
The use of overnight fasting copeptin and glucagon stimulated copeptin to diagnose arginine vasopressin deficiency in a tertiary centre
Date not available
Phenotypic heterogeneity associated with proglucagon-expressing tumours is due to differential processing and secretion of proglucagon-derived peptides
2015-12-1010Dec2015
Removal of the dominantly secreting adrenal lateralized by bilateral adrenal venous sampling (BAVS) with glucagon stimulation significantly alleviated hypertension in patients with bilateral adrenal pheochromocytoma
2012-01-0505Jan2012
Effect of bariatric surgery on serum glucagon like peptide-1 concentration and metabolic parameters among obese type 2 diabetics
2013-01-0404Jan2013
An Ongoing Phase 2 Study of HM15136, a Novel Long-acting Glucagon Analogue, in Subjects with Congenital Hyperinsulinism (ACHIEVE, Outline Protocol)
Date not available
Comparison of GHRH + arginine vs glucagon test for the evaluation of growth hormone secretion status in a cohort of adults with Prader-Willi syndrome (PWS)
2017-03-0505Mar2017
Glucagon-like-1 Receptor imaging specifically localizes insulinomas in patients with Multiple Endocrine Neoplasia Type 1 (MEN-1)
Date not available
Could <sup>99m</sup>Tc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?
2015-01-0505Jan2015
Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice
2014-01-0303Jan2014
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin&#150;angiotensin&#150;aldosterone system in healthy men
2013-01-0404Jan2013
Monitoring thyroid function in diabetic patients on treatment with glucagon-like peptide 1 analog
2011-01-0404Jan2011
Effects of glucagon-like peptide-1 receptor agonists on bone blow flow and architecture in diabetic mice
Date not available
Development of severe gastroparesis and gastric food bezoar following administration of glucagon-like peptide 1-receptor agonist (GLP1-RA) therapy
Date not available
The role of Glucagon-Like Peptide 1 Receptor Agonists for Weight Control in Individuals with Acquired Hypothalamic Obesity- A Systematic Review
Date not available
Proglucagon processing can be altered to produce GLP-1 in pancreatic alpha cells
2006-01-1010Jan2006
The comparison of combination test either with 1 &#956;g acth test and glucagon test for the evaluation of hypothalamo-pituitary-adrenal axis in patients with pituitary disorders
2018-08-0505Aug2018
Glucagon-like peptide-1 analogues: a new way to quit smoking? SKIP &#150; a randomised controlled study
2022-07-0505Jul2022
A comparison of glucagon stimulation and insulin tolerance test in young adults followed craniospinal irradiation
2019-01-0505Jan2019
Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to a glucagon-like peptide-1 receptor agonist: A real-world experience
Date not available
Acute effects of co-infusion of peptide YY (3&#150;36) and glucagon-like peptide-1 on insulin secretion and insulin sensitivity
2013-01-0303Jan2013
Audit of pituitary dysfunction after traumatic brain injury: caution in interpretation of glucagon stimulation test in diagnosis of GH and ACTH deficiency.
2012-01-0505Jan2012
Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in polycystic ovary syndrome
2008-01-0505Jan2008
11.12. Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist
2019-12-0909Dec2019
Abnormalities of glucagon suppression and stimulation of insulin secretion in response to rising glucose concentrations interact in impaired fasting glucose and impaired glucose tolerance
Date not available
Stable analogues of the dual agonist dogfish glucagon show better therapeutic potential than exendin-4 in diet induced obese diabetic mice
2015-01-0505Jan2015
Proglucagon peptide secretion post Roux-en-Y gastric bypass: one year prospective study
Date not available
Obestatin improves <em>in vitro</em> generation of novel insulin and glucagon secreting islet-like cell clusters from islet-derived non differentiated cells
2011-01-0404Jan2011
Innervation and vascularization into islets of langerhans in the presence or absence of proglucagon-derived peptides
2012-01-0505Jan2012
Cortisol responses to the insulin tolerance test and glucagon stimulation tests in children with idiopathic short stature and idiopathic isolated growth hormone deficiency
2015-04-1111Apr2015
The impact of subcutaneous infusions of three anorexigenic gut hormones glucagon-like peptide-1, oxyntomodulin and peptide YY (GOP) on the psychological health of obese diabetic patients
2019-06-1111Jun2019
The effect of chronic hypothalamic-pituitary-adrenal axis activation on hypothalamic glucagon-like peptide-1 action in an animal model of depression and <em>in vitro</em> studies
2017-03-0505Mar2017
Relationship between Insulin and somatostatin secretory response to Glucagon-like peptide-1 (GLP-1) and glucose concentration in perifused rat pancreatic islet cells
Date not available
Localisation of insulinoma: comparison of glucagon-like peptide 1 receptor SPECT/CT, PET/CT, and MRI: preliminary results of a prospective clinical study
2015-01-0505Jan2015
The effectiveness of glucagon-like peptide 1 receptor agonist and prebiotic on short-chain fatty acids and carbohydrate metabolism in patients with carbohydrate metabolism violation
Date not available
Evaluation of GH deficiency and central adrenal insufficiency in patients following craniospinal irradiation in young ages: comparison between the glucagon stimulation test and the insulin tolerance test
2013-01-0404Jan2013
The short synacthen test may be more sensitive than the glucagon stimulation test in assessing the hypothalamic&#150;pituitary&#150;adrenal axis: a retrospective audit
2013-01-0404Jan2013
No secreting multiple glucagonoma: one case
2010-01-0404Jan2010
A rare association of glucagonoma and gastric gastrinoma
2023-02-0505Feb2023
Effects of glucagon-like peptide 1 receptor agonist on short-chain fatty acids, carbohydrate and lipid metabolism in patients with type 2 diabetes
2019-01-0505Jan2019
Addition of sodium-glucose co-transporter type 2 inhibitors to diabetic patients type 2 in treatment with glucagon-like peptide-1 agonists: clinical results
2018-08-0505Aug2018
Glucagon-like peptide-1 (GLP-1) receptor agonists as a new treatment option for hypothalamic obesity in the paediatric population: Preliminary data from a tertiary paediatric endocrine centre
2023-01-1111Jan2023
Precision medicine in type 2 diabetes mellitus: Unraveling the role of TCF7L2, CTRB1/2, and GLP-1R genetic variants in response to treatment with glucagon-like peptide-1 receptor agonists
2024-06-0505Jun2024
Characterising the G-protein signalling mechanisms activated by short chain fatty acids in human enteroendocrine cells which mediate production and release of the anorectic gut hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)
Date not available
Glucagonoma: does the clinical expression depend on the presence of inherited disease?
2006-04-1212Apr2006
Metastatic glucagonoma transforming to an insulinoma
2004-01-0303Jan2004
Proglucagon peptide family responses after RYGB surgery in obese patients with type 2 diabetes
Date not available
Rare Case of Metastatic Glucagonoma, A Diagnostic Twist
2023-10-0505Oct2023
Glucose-dependent insulinotropic peptide (GIP) stimulates Glucagon-like peptide (GLP)-1 from human and mouse pancreatic islets partly via alpha-cell-derived IL-6
Date not available
Glucagonoma syndrome &#150; treatment with intensive insulin and high dose vitamin B
2006-04-1212Apr2006
Metastatic glucagonoma de-differentiated to an insulinoma: response to embolization
2004-01-0303Jan2004
Pancreatic neuroendocrine tumour: from glucagonoma to aggressive insulinoma
2024-06-0505Jun2024
Molecular control of glycogen storage in muscle
2012-01-0303Jan2012
Glycogen hepatopathy - a case series
2022-07-0505Jul2022
iPSC-derived hepatocytes as a novel tool for glycogen storage disease 1A (GSD1A) modelling and drug screening
Date not available
An unusual association of a familial MEN1 with renin co secretion form a glucagonoma
2023-02-0505Feb2023
Malnutrition cause of Secondary Osteoporosis after surgical operation of Glucagonoma
2013-01-0404Jan2013
Management of necrolytic migratory erythema with lanreotide a patient diagnosed with pancreatic glucagonoma: A rare case report
2023-02-0505Feb2023
A rare case of glucagonoma presented with high serum amilase and lipase
Date not available
Coexistence of double small insulinomas with a small glucagonoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1)
2011-01-0404Jan2011
Receptor-based scintigraphic imaging of insulinoma and glucagonoma in MEN-1
Date not available
Hepatic and brain metabolism in young adults with glycogen storage disease type 1
Date not available
Novel pathogenetic mutation of MEN1 gene causing hyperparathyroidism, pancreatic glucagonoma, adrenal adenoma, and collagenomas
2022-07-0505Jul2022
A very rare case of familial glucagonoma with renin co-secretion and hypokalemia in MEN1 multiple neoplasia
2023-02-0505Feb2023
Challenges in the diagnosis and management of a case of glucagonoma first presenting as a localised genital rash
2015-12-1010Dec2015
Hypothyroidism in Glycogen Storage Disease Type 1b and Management
2023-02-0505Feb2023
Osteoporosis in a patient with Glycogen Storage Disease Type I
2023-02-0505Feb2023
Effects of glucagon-like peptide 1 analogue on eating behavior in patients with obesity
2022-07-0505Jul2022
Osteoporosis as a major risk for patients with glycogen storage disease
2009-01-0303Jan2009
Glycogen-Storage Disease Type VI in a Girl Presenting with Recurrent Ketotic Hypoglycaemia but No Hepatomegaly
Date not available
Hepatic Glycogen Synthasedeficiency Associated with Growth Hormone Deficiency: A Case Report
Date not available
Hypoglycemia as a result of growth hormone deficiency and Glycogen storage disease type 0a in a patient with short stature &ndash; case report
Date not available
Glycogen hepatopathy- a rare and frequently misdiagnosed hepatic complication of diabetes mellitus
2022-07-0505Jul2022
Hypogonadotropic hypogonadism in a male patient with glycogen storage disease type 1A
2019-01-0505Jan2019
Calcium as a marker of metabolic decompensation in glycogen storage disease type-1a
Date not available
Diabetes Mellitus a Late Complication in Glycogen Storage Disease Type 1b
Date not available
The role of advanced glycation end products on vertebral fractures in patients with acromegaly
2022-07-0505Jul2022
Association between advanced glycation end products (AGEs) and diabetic retinopathy in Latvia
2023-02-0505Feb2023
Endocrine Complications of Patients with Hepatic Type of Glycogen Storage Disease
Date not available
Extreme Hypercalcaemia: Watch for Glycogen Storage Disease Type 1a with Hyperinsulinism
Date not available
Novel ultrasound approaches permit the visualisation of the microvascular effects of glucagon-like peptide-2 in the gut with unprecedented resolution
Date not available
Long-term treatment with glucagon-like peptide-1 (GLP-1) receptor agonists: a real-life study
2022-07-0505Jul2022
Ketogenic diet and Glucagon-like peptide 1 (GLP1) receptor agonists for obesity: our experience
2022-07-0505Jul2022
Effects of Glucagon-Like Peptide-1 Analogs on Sexual Desire: A randomized, double-blind, placebo-controlled crossover trial
2023-02-0505Feb2023
The role of glucagon like peptide - 1 (GLP-1) receptor agonists in the treatment of type 2 diabetes mellitus
2019-01-0505Jan2019
Tubular and glomerular biomarkers of kidney injury on glucagon-like peptide-1 (GLP-1) therapy in type 1 diabetic patients
2017-03-0505Mar2017
Localization of benign insulinomas using glucagon-like peptide-1 receptor (GLP1-R) SPECT/CT and PET/CT in a prospective clinical study
Date not available
Glucagon Stimulation test (GST) is superior to Short Synacthen test (SST) in diagnosing Adrenal insufficiency
2018-02-1111Feb2018
Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients
2012-01-0505Jan2012
Prospective comparison of the glucagon stimulation test (GST) with the insulin tolerance test (ITT) in patients following pituitary surgery
2008-01-0505Jan2008
Predictors of glucagon-like peptide-1 responses following oral glucose tolerance test in 3 ethnic groups of Malaysia
Date not available
Ethnicity and its influence on post-oral glucose tolerance test glucagon-like peptide-1 responses
Date not available
Omentin-1, vaspin, peptide YY and oxyntomodulin levels in cord blood newborns and correlation with anthropometric parameters
Date not available
Effects of glucagon-like peptide-1 receptor agonists on copeptin in healthy volunteers and patients with primary polydipsia
Date not available
Effects of glucagon-like peptide-1 analogs on prolactin: a randomized, double-blind, placebo-controlled crossover trial
2024-06-0505Jun2024
Management of early onset obesity due to melanocortin 4 receptor (MC4R) defect with glucagon- like -peptide receptor agonist
Date not available
Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis
2022-07-0505Jul2022
The influence of advanced glycation end-products (AGEs) on diabetic retinopathy progression
2023-02-0505Feb2023
Advanced glycation end products association in patients with diabetes mellitus
2023-02-0505Feb2023
Advanced glycation endproducts (AGE) and severity of diabetic retinopathy association analysis in latvia
2024-06-0505Jun2024
Recurrent Ketosis after Prolonged Exercise in Type 1 Diabetes: The Need for Glycogen Replacement Strategies: Case Report
Date not available
A Case Report: Why Continuous Glucose Monitoring in Conjunction with the GluCare. Health Care Model is Important in a Patient Newly Diagnosed with Type 2 Diabetes
2023-02-0505Feb2023
Effect of maternal cold exposure on hepatic glycogen content, peroxisome proliferator-activated receptor alpha and insulin-like growth factor-II mRNA expression in the neonate
2005-07-1111Jul2005
Growth hormone deficiency and Glycogen storage disease type 0 in a girl with short stature and hypoglycemia: a case report
Date not available
<p>A challenging case of adult-onset non-diabetic hypoglycemia: unveiling glycogen storage disease type vi (hers disease)</p>
Date not available
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
2019-01-0505Jan2019
Continuous glucose monitoring in glycogen storage disease type Ia &#150; a major improvement for patients
2017-03-0505Mar2017
The effects of vitamin D on advanced glycation end-products in prediabetic and type 2 diabetic patients with vitamin D deficiency
Date not available
Advanced glycation end product associated skin autofluorescence and serum corboxymethyl lysine levels in acromegaly
2013-01-0404Jan2013
<i>Emblica officinalis</i> stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation
2010-01-0404Jan2010
<i>Terminalia bellerica</i> (Belliric Myrobalan) stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation
2009-01-0404Jan2009
EFFECTS OF SYZYGIUM (i) CORDATUM (i) LEAF EXTRACT ON PLASMA GLUCOSE AND HEPATIC GLYCOGEN IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
2004-01-1111Jan2004
Impact of Glucagon-like peptide-1 (GLP-1) receptor agonists on insulin resistance and weight as prevention of type 2 diabetes at overweight and obesity patients
2023-02-0505Feb2023
Localization of benign insulinomas using glucagon-like peptide-1 receptor (GLP1-R) SPECT/CT and PET/CT and MRI in a prospective clinical study
2017-03-0505Mar2017
Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: Preliminary experience from a tertiary paediatric endocrine centre
Date not available
9.9. Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation
Date not available
Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study
Date not available
Nonclassical congenital adrenal hyperplasia in a young patient with Type 1a Glycogen storage disease: is there a novel link between glucose metabolism and adrenal steroidogenesis?
2018-08-0505Aug2018
Insulinoma- A complicated presentation in a rare case scenario
2007-01-0303Jan2007
Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I
Date not available
Hypothalamic-pituitary-adrenal axis, type 1b glycogen storage disease &#38; pregnancy
2024-06-0505Jun2024